Si Min Zhang
Research Specialist
E-mail: si.zhang@ki.se
Visiting address: SciLifeLab, Tomtebodavägen 23, 17165 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Rudd, 171 77 Stockholm
Articles
- Article: NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS. 2024;:1-6
- Article: ISCIENCE. 2024;27(2):108907
- Article: NATURE CANCER. 2022;3(2):156-172
- Article: CELL CHEMICAL BIOLOGY. 2021;28(12):1693-1702.e6
- Article: CELL DEATH AND DISEASE. 2021;12(7):709
- Article: BMC RESEARCH NOTES. 2021;14(1):27
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2021;296:100568
- Article: NATURE CHEMICAL BIOLOGY. 2020;16(10):1120-1128
- Article: EMBO MOLECULAR MEDICINE. 2020;12(3):e10419
- Article: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY. 2018;101:103-112
- Article: BIOCHEMISTRY. 2015;54(9):1819-1830
All other publications
- Preprint: BIORXIV. 2022
- Corrigendum: CELL DEATH AND DISEASE. 2022;13(8):672
- Preprint: BIORXIV. 2020
- Preprint: BIORXIV. 2020
Selected grants
- Targeting host nucleotide metabolism for personalized antimetabolite therapiesÅke Wibergs Stiftelse1 January 2023
Grants
- Stiftelsen Clas Groschinskys Minnesfond1 January 2024
- Targeting host nucleotide metabolism for personalized antimetabolite therapiesStiftelsen Lars Hiertas Minne1 January 2023
- Stiftelsen Clas Groschinskys Minnesfond1 January 2023
- Exploiting nucleotide metabolism for improved leukemia therapyFelix Mindus contribution to Leukemia Research1 January 2022
- Targeting nucleotide-sanitizing enzymes to improve antiviral therapiesKI Foundation for Virus Research1 January 2022
- Overcoming drug resistance in acute leukaemias with SAMHD1 inhibitorsDr Åke Olsson Foundation for Hematological Research1 January 2022
- Understanding and exploiting drug resistance in cancer among elderly - targeting nucleotide-metabolizing enzymes SAMHD1 and NUDT15Loo and Hans Osterman Foundation for Medical Research1 January 2022
- Targeting host nucleotide metabolism for personalized antimetabolite therapiesÅke Wibergs Stiftelse1 January 2022
- Understanding and exploiting drug resistance in cancer - targeting the dNTPase SAMHD1KID - partial funding to doctoral students at Karolinska Institutet1 January 2021
- Targeting nucleotide-sanitizing enzymes to improve treatment of hematological malignanciesFelix Mindus contribution to Leukemia Research1 January 2020
- Targeting nucleotide-sanitizing enzymes to improve antiviral therapiesKI Foundation for Virus Research1 January 2020
- Targeting nucleotide-sanitizing enzymes to improve treatment of hematological malignanciesFelix Mindus contribution to Leukemia Research1 January 2019
Employments
- Research Specialist, Department of Oncology-Pathology, Karolinska Institutet, 2023-
- Postdoctoral Researcher, Department of Oncology-Pathology, Karolinska Institutet, 2019-2023
Degrees and Education
- Doctor Of Philosophy, Biomedical Science, Interaction-mediating sequences within Class I viral fusion glycoproteins: their roles in viral infection and in applications, School of Biological Sciences, Nanyang Technological University, 2016
- Degree Of Doctor Of Philosophy, Department of Laboratory Medicine, Karolinska Institutet, 2015